Skip to content

    Recently Viewed


      Lede-What You Need to Know About Johnson & Johnson's 2020 First-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2020 first-quarter earnings

      Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon
      Johnson & Johnson First Quarter 2020 Earnings infographic

      This morning, Johnson & Johnson shared its first-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “We recognize the unfortunate impact that the COVID-19 pandemic has had on people, communities, businesses and the world. While Johnson & Johnson’s first quarter results were strong, reflecting the resiliency of our diversified business, that narrative has understandably taken a back seat to the more pressing concern of addressing COVID-19,” says Joseph Wolk, Executive Vice President, Chief Financial Officer. “We are not only confident in winning the fight against this public health crisis with efforts such as our collaboration to co-fund investment in vaccine development, but we also have confidence in the fundamentals of our entire business, which are remarkably strong for the long term.”

      For more details about the company’s 2020 first-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.

      Johnson & Johnson First Quarter 2020 Earnings infographic

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.